Average Insulin Copays | What You Can Expect

Most insured people pay around $25–$35 per month for insulin copays, but caps and plans can push costs closer to $0 or above $100.

Insulin keeps blood sugar in check, but the bill at the pharmacy counter can feel confusing and unpredictable. One person pays a small flat fee, another pays a much larger amount until a deductible is met, and a third pays almost nothing because of special caps or savings programs. When people talk about “average insulin copays,” they’re usually trying to understand where their own bill might land inside this wide range.

This article focuses on insulin copays in the United States and explains how plan type, laws, and assistance programs shape what you pay. It walks through typical monthly out-of-pocket ranges, shows how Medicare’s $35 cap fits in, and shows you practical ways to estimate and lower your own average insulin copay without getting lost in dense insurance jargon.

Every plan is different, so the goal here is not to give one perfect dollar figure for everyone. Instead, you’ll see realistic ranges backed by public data, plus concrete steps you can take with your insurer, pharmacy, and diabetes care team to bring those numbers down.

How Insulin Copays Work

Before looking at averages, it helps to clear up what “copay” means at the pharmacy. A copay is a set dollar amount you pay for a covered drug, such as $25 for a 30-day insulin refill, while your plan pays the rest. It stays the same each time you fill that prescription, as long as you stay in the same tier and benefit phase.

Insulin costs at the counter are usually a mix of several pieces of plan design:

• Deductible: The amount you pay each year before your plan starts sharing drug costs. Some plans waive the deductible for insulin.
• Copay: A flat fee, such as $10, $25, or $35 per monthly supply.
• Coinsurance: A percentage of the drug’s price, such as 20%, instead of a flat copay.
• Out-of-pocket maximum: The yearly cap on what you pay across covered services. After you hit it, covered drugs cost $0 for the rest of the year.

Your insulin bill can shift during the year as you move from the deductible phase to regular coverage and then toward the out-of-pocket maximum. That is why some people see a very high copay the first time they fill insulin in January and a much lower amount later in the year.

Average Insulin Copays By Plan Type

There is no single nationwide number that fits everyone, but research and policy changes give a decent picture of where insulin copays often land under different types of coverage. One federal report found that people under 65 with private insurance paid an average of about $613 per year out of pocket for insulin, which works out to a little over $50 per month on average. That average hides a wide spread: some people pay far less, while others pay several times more.

Employer And Individual Market Plans

Most working-age adults get insulin coverage through employer plans or individual plans purchased on the marketplace. In these plans, insulin is usually placed on a preferred or non-preferred brand tier. A preferred insulin might have a flat copay such as $25–$35 per month, while a non-preferred option could cost $50–$100 or more per fill, especially before any deductible is met. A Congressional Research Service report, using 2019 data, estimated average annual out-of-pocket insulin costs of $613 for privately insured people under 65, but also noted wide variation across plans and states.

States have started to step in. Many state-regulated plans now have insulin copay caps, such as $25, $30, or $35 per 30-day supply, while others cap a broader basket of diabetes drugs and supplies. The American Diabetes Association maintains an updated map of state insulin copay caps that shows how generous or limited these laws are in each state. In practice, someone on a plan with a strong cap might see a monthly insulin copay closer to $25–$35, while someone on a plan without a cap might see $60 or more per month, at least until other caps or assistance kick in.

Medicare Insulin Copays

For people with Medicare, the Inflation Reduction Act reshaped insulin cost sharing. Starting January 1, 2023, Medicare Part D prescription drug plans must cap out-of-pocket costs for each covered insulin product at $35 for a one-month supply. No Part D deductible can apply to that insulin. A similar $35 monthly cap now applies under Medicare Part B for certain insulin delivered through durable medical equipment, such as pumps.

This $35 limit applies per insulin product and per month’s supply. Someone using both a basal and a rapid-acting insulin could pay up to $70 per month if both are on the plan’s covered list, while a person using a single insulin would pay up to $35. Some enhanced plans or assistance programs bring the effective copay even lower, but the cap gives a clear ceiling for most Medicare users.

Medicaid, CHIP, And Other Public Coverage

Medicaid and Children’s Health Insurance Program (CHIP) coverage for insulin varies by state, but many enrollees see low or zero copays for insulin and other essential diabetes drugs. Some states charge only a token amount such as $1–$4 per prescription, while others waive insulin copays entirely for certain groups.

Because income limits and benefit designs differ from state to state, there is no single Medicaid average insulin copay. Still, compared with private coverage, Medicaid tends to keep insulin copays in the single-digit range, with stronger protections for people who would otherwise forgo refills because of cost.

Uninsured Patients And Cash Prices

People without insurance are often exposed to the list price of insulin, which can be several hundred dollars per month. In that case, there is no “copay” in the typical sense. Instead, the full cash price functions like an out-of-pocket bill for each refill.

Several manufacturers now run value programs that promise insulin for about $35 per month for eligible people, including some uninsured patients, and nonprofit groups point people toward charity care and discount cards. The American Diabetes Association’s affordable insulin resources and similar tools can dramatically reduce effective per-month spending for those who qualify, moving real-world costs closer to the typical insured copay range.

Which Factors Shape Your Insulin Copay The Most?

Two people with the same prescription can pay very different amounts at the counter. That gap usually comes down to a handful of factors that interact with each other over the course of the year.

Plan Design And Benefit Phases

The way your plan splits costs with you may matter more than the list price of the insulin itself. Key plan design features include:

• Deductible rules: Some plans apply the deductible to insulin, so you pay the full drug price until that threshold is met. Others treat insulin as preventive care and cover it with a copay from day one.
• Flat copay versus coinsurance: A flat copay keeps your bill predictable. Coinsurance, such as 20% of the price, leads to bigger swings as list prices change.
• Tier placement: Insulin on a preferred tier costs less than the same drug on a non-preferred or specialty tier.
• Mail-order versus retail: Some plans reduce the average monthly copay when you fill a 90-day supply through mail order.

Plans in the employer and individual markets often update these rules each year. A plan that treated insulin generously one year might move it to a higher tier the next, while another plan might start covering a biosimilar at a lower copay to encourage switching.

Insulin Type, Dose, And Supply

Rapid-acting, long-acting, mixed, and biosimilar insulins can sit on different tiers, with different copays or coinsurance rates. Pens can have a different cost structure than vials. Higher daily doses can also influence how many pens or vials you need each month, which then affects whether a single copay covers your full monthly needs or whether you need more than one fill.

Some plans base copays on the days’ supply instead of the number of pens or vials. If so, a 90-day fill might use a single copay that roughly triples the per-visit charge but lowers the average monthly copay across the three months. Other plans charge per box or per prescription, which can shift the math for people with higher doses.

State Laws, Federal Caps, And Assistance Programs

Policy changes have begun to place firm ceilings on insulin copays in many settings. State copay cap laws now limit monthly out-of-pocket insulin costs on state-regulated plans in many states, often to $25 or $35 per 30-day supply. The American Diabetes Association’s state insulin copay caps page shows which states have passed these protections and how they apply to different plan types.

On the federal side, Medicare’s $35 monthly cap for covered insulin products under Part D and Part B reshapes the upper end of insulin copays for older adults and some people with disabilities. Research published through the National Institutes of Health shows that this cap is expected to save Medicare beneficiaries hundreds of millions of dollars in aggregate insulin spending.

At the same time, drug makers have expanded value programs that limit what insured or uninsured people pay at the counter, often targeting a $35 per month price point. Professional groups such as the American Diabetes Association publish up-to-date information on these assistance programs and help people match their situation to the right mix of resources.

How To Estimate Your Own Average Insulin Copay

Even with general ranges, you still need to know what your own plan will charge. A short review of your paperwork and a quick call or online chat with your insurer can usually give a clear answer.

Step 1: Check Your Plan’s Drug List And Summary

Start with your plan’s summary of benefits and formulary (drug list). These documents list tiers, copays, coinsurance rates, and any special rules. On most insurer websites you can search for your exact insulin by brand name and see:

• Which tier it sits on and whether there is a preferred biosimilar alternative.
• Whether the plan charges a flat copay or a percentage of the drug’s price.
• Whether insulin is covered before the deductible or only after you meet it.

If you cannot find this information online, you can call the member services number on your insurance card and ask the representative to walk through your insulin coverage and expected copay for a 30-day and 90-day supply.

Step 2: Map Out A Real-World Fill Scenario

Once you know how your plan treats your insulin, you can map out what you’ll pay over the year. Here is a simple way to do that:

1. List how many pens or vials you usually need each month for each insulin you use.
2. Check which benefit phase you are in now: before the deductible, after the deductible, or near your out-of-pocket maximum.
3. Apply the rules from your plan: if you are before the deductible and insulin is not covered until it is met, estimate the full month’s price; if insulin is covered outside the deductible, use the flat copay or coinsurance percentage given.
4. Repeat the calculation for later in the year, once the deductible is met, and again in months when you expect to hit your out-of-pocket maximum.

These steps give you a rough yearly picture: several months with higher spending early on, then a series of months with lower, predictable copays, and possibly a few months at the end of the year when you hit your out-of-pocket limit and copays drop to zero.

Step 3: Adjust For Caps And Assistance

Next, fold in any state copay caps, federal rules, or savings programs that apply to you. If you live in a state with a legal cap on insulin cost sharing for state-regulated plans, your per-month copay for each covered insulin cannot exceed that cap, even if your plan’s standard tier chart lists a higher amount. A quick check of your state’s page on the American Diabetes Association’s insulin copay caps map can confirm this.

If you have Medicare, the $35 monthly cap for each covered insulin gives you a clear ceiling for most situations. For uninsured people or those facing high coinsurance, manufacturer savings cards and nonprofit assistance can bring average insulin spending down toward that same $35 range, especially for those who meet income and program rules.

Practical Ways To Lower Your Average Insulin Copays

If your current insulin copays feel heavy, there are several levers you can pull with your care team, insurer, and local resources. Each one may shave a piece off your monthly bill; together, they can materially change your average spending across the year.

Ask About Lower-Tier Or Biosimilar Options

Plans often cover at least one basal and one rapid-acting insulin on a preferred tier. If your current product sits on a higher tier, your prescriber may be able to switch you to a clinically similar insulin that your plan treats more favorably. Pharmacists can help flag when a lower-tier option might fit your regimen, and your prescriber can confirm whether a change makes sense for your control and comfort.

Biosimilar and unbranded insulins are increasingly placed on preferred tiers at lower copays. Over time, this shift can bring down the average insulin copay across large groups of patients, even if your own bill changes only when you and your prescriber decide a switch is appropriate.

Use Copay Caps And Medicare Rules To Your Advantage

If you live in a state with a legal cap on insulin copays for state-regulated plans, use that cap during conversations with your insurer or employer benefits office. If your bill exceeds the stated cap for a 30-day supply, you can ask the plan to correct the charge to match state law.

For Medicare enrollees, the $35 monthly cap for each covered insulin under Part D and Part B serves as a strong backstop. During open enrollment, check that your preferred insulin remains covered and that you understand how many months of the year you will pay the capped amount. Selecting a plan that covers your exact formulation can prevent surprise costs and keep your average copay within the intended range.

Tap Into Affordable Insulin Resources

Several organizations maintain up-to-date lists of programs that reduce insulin copays and out-of-pocket costs. The American Diabetes Association’s affordable insulin tools outline patient assistance programs, manufacturer value cards, and nonprofit funds that help people who are uninsured or facing steep cost sharing. Professional groups and diabetes educators also publish insulin cost-saving resource guides that bring many of these options into one place.

When applying for assistance, gather pay stubs, insurance documents, and prescription information in advance. Many programs base eligibility on household income and insurance status. Once approved, you may receive a copay card you present at the pharmacy, a mail-order supply at reduced cost, or direct help paying existing bills, all of which change your effective average insulin copay across the year.

Coordinate Refills And Supplies

Finally, small adjustments in how you refill insulin can nudge your monthly costs down. Align refill dates so that pens or vials do not expire unused, check whether a 90-day supply through mail order lowers your per-month cost, and review your dosing schedule with your prescriber if your needs change. These steps help ensure you are paying for insulin you actually use rather than overstocking at higher prices.

Average insulin copays will continue to shift as more state laws, federal rules, and manufacturer programs roll out. Staying familiar with your plan documents, keeping an eye on state and federal policy updates, and leaning on reputable diabetes organizations for current resources can help you keep your own costs anchored near the lower end of the typical ranges, rather than the upper end.

Send us your feedbackTell us what you thought about this post

⚠Please use a real email you check. If it's fake or mistyped, your message won't reach us and we can't reply — wrong addresses are rejected automatically.

Name *Email *

Your comment *

Quick check — what is …? *

Send feedback